Jackson Orem
#105,023
Most Influential Person Now
Ugandan oncologist
Jackson Orem's AcademicInfluence.com Rankings
Jackson Oremphilosophy Degrees
Philosophy
#11520
World Rank
#15874
Historical Rank
Logic
#9042
World Rank
#11403
Historical Rank
Download Badge
Philosophy
Jackson Orem's Degrees
- Doctorate Oncology Makerere University
Why Is Jackson Orem Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jackson Orem is a physician, medical oncologist and researcher in Uganda. He has served as the director of the Uganda Cancer Institute, since 2004. Background and education Orem was born in Uganda and he attended local primary and secondary schools. His father was a driver and salesman. His mother was a housewife. After high school, he was admitted to Makerere University School of Medicine, the oldest in East Africa. He graduated with a Bachelor of Medicine and Bachelor of Surgery degree. After internship, he was re-admitted to Makerere University to pursue a Master of Medicine degree , in Internal Medicine, graduating in the early 2000s.
Jackson Orem's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Improvement of pathology in sub-Saharan Africa. (2013) (199)
- Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. (2007) (188)
- A Molecular Link between Malaria and Epstein–Barr Virus Reactivation (2007) (176)
- Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. (2019) (120)
- AIDS-associated cancer in developing nations (2004) (90)
- Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. (2009) (78)
- Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children (2010) (67)
- Contribution of HIV infection to mortality among cancer patients in Uganda (2013) (63)
- Exploring stigma as a barrier to cancer service engagement with breast cancer survivors in Kampala, Uganda (2016) (58)
- Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection (2009) (56)
- Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda (2009) (54)
- Gender Differences in Clinical Presentation and Outcomes of Epidemic Kaposi Sarcoma in Uganda (2010) (51)
- Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. (2016) (50)
- The prevalence and distribution of non-communicable diseases and their risk factors in Kasese district, Uganda (2013) (47)
- Survival by AIDS defining condition in rural Uganda (2000) (47)
- Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa (2010) (45)
- Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa. (2009) (44)
- Predictors of Survival After a Diagnosis of Non-Hodgkin Lymphoma in a Resource-Limited Setting: A Retrospective Study on the Impact of HIV Infection and Its Treatment (2011) (44)
- Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey (2013) (40)
- A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999–2008 (2015) (38)
- The management of children with Kaposi sarcoma in resource limited settings (2013) (32)
- Clinical characteristics, treatment and outcome of childhood Burkitt's lymphoma at the Uganda Cancer Institute. (2011) (31)
- Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis (2013) (29)
- EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda (2010) (28)
- The Roles of National Cancer Research Institutions in Evolving a Comprehensive Cancer Control Program in a Developing Country: Experience from Uganda (2009) (28)
- Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. (2020) (28)
- Priorities for cancer research in low- and middle-income countries: a global perspective (2022) (27)
- HPV Infection and EGFR Activation/Alteration in HIV-Infected East African Patients with Conjunctival Carcinoma (2010) (25)
- Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory (2012) (24)
- Prognosis and delay of diagnosis among Kaposi’s sarcoma patients in Uganda: a cross-sectional study (2014) (23)
- Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa (2006) (22)
- High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis. (2017) (21)
- Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System. (2016) (21)
- As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial (2018) (21)
- Platelet transfusion therapy in sub‐Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions (2016) (21)
- Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter (2018) (20)
- Burkitt lymphoma in UGANDA, the legacy of Denis Burkitt and an update on the disease status (2012) (20)
- Current investigations and treatment of Burkitt's lymphoma in Africa (2008) (19)
- Association Between HIV Infection and Cancer Stage at Presentation at the Uganda Cancer Institute (2017) (18)
- The cost effectiveness of treating Burkitt lymphoma in Uganda (2019) (18)
- Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children (2017) (17)
- Intestinal parasites in Kaposi sarcoma patients in Uganda: indication of shared risk factors or etiologic association. (2008) (16)
- Clinical characteristics of Burkitt's lymphoma from three regions in Kenya. (2006) (16)
- Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda (2019) (16)
- Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin. (2003) (15)
- Epstein‐Barr virus viral load and serology in childhood non‐Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: Implications for disease risk and characteristics (2014) (15)
- Presentation and Outcomes of Childhood Cancer Patients at Uganda Cancer Institute (2019) (14)
- Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda. (2016) (14)
- Prostate Cancer Burden at the Uganda Cancer Institute (2016) (14)
- Challenges faced by cancer patients in Uganda: Implications for health systems strengthening in resource limited settings. (2021) (13)
- Peer Mentoring at the Uganda Cancer Institute: A Novel Model for Career Development of Clinician-Scientists in Resource-Limited Settings (2018) (13)
- Infection-Related Cancers in Sub-Saharan Africa: A Paradigm for Cancer Prevention and Control (2012) (12)
- ACR BI-RADS Use in Low-Income Countries: An Analysis of Diagnostic Breast Ultrasound Practice in Uganda. (2016) (12)
- Breast cancer early detection and diagnostic capacity in Uganda (2020) (12)
- HIV Status and Associated Clinical Characteristics Among Adult Patients With Cancer at the Uganda Cancer Institute (2017) (11)
- Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation (2009) (11)
- Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda (2017) (11)
- Toward Optimization of Cancer Care in Sub-Saharan Africa: Development of National Comprehensive Cancer Network Harmonized Guidelines for Sub-Saharan Africa (2020) (10)
- Capacity building for the clinical investigation of AIDS malignancy in East Africa. (2005) (10)
- Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers (2020) (10)
- Anthracycline induced cardiotoxicity in adult cancer patients: a prospective cohort study from a specialized oncology treatment centre in Uganda (2019) (9)
- A comparative investigation of methods for longitudinal data with limits of detection through a case study (2016) (9)
- Feasibility study of serial lumbar puncture and acetazolamide combination in the management of elevated cerebrospinal fluid pressure in AIDS patients with cryptococcal meningitis in Uganda (2005) (9)
- Engagement in HIV Care and Access to Cancer Treatment Among Patients With HIV-Associated Malignancies in Uganda (2019) (8)
- Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments. (2014) (8)
- Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda (2017) (7)
- Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report (2011) (7)
- Cutaneous T-cell lymphoma in sub-Saharan Africa. (2013) (7)
- Survey to Assess Knowledge and Reported Practices Regarding Blood Transfusion Among Cancer Physicians in Uganda (2018) (7)
- Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease. (2006) (6)
- Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma (2021) (6)
- Cancer prevention and control: Kaposi’s sarcoma (2019) (6)
- Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads (2021) (6)
- Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma. (2006) (6)
- Disseminated aspergillus fumigatus infection: case report. (1998) (5)
- Acceptability and preferences for self‐collected screening for cervical cancer within health systems in rural Uganda: A mixed‐methods approach (2020) (5)
- User Requirements for an Electronic Medical Records System for Oncology in Developing Countries: A Case Study of Uganda (2017) (5)
- Renal glycosuria treated as diabetes mellitus: case report. (1997) (5)
- Increasing access to quality anticancer medicines in low- and middle-income countries - the experience of Uganda. (2021) (4)
- Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda. (2016) (4)
- Capacity building for hematologic malignancies in Uganda: a comprehensive research, training, and care program through the Uganda Cancer Institute-Fred Hutchinson Cancer Research Center collaboration. (2018) (4)
- Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda. (2017) (4)
- Strengthening Laboratory Diagnostic Capacity to Support Cancer Care in Uganda. (2020) (4)
- Cancer Control in Africa 2 Improvement of pathology in sub-Saharan Africa (2013) (4)
- Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates (2010) (4)
- Gastrointestinal malignancies at five regional referral hospitals in Uganda (2017) (4)
- Global disparities in access to cancer care (2022) (4)
- Agenesis of the right kidney with a retroperitoneal cyst arising in a persistent metanephros. (1947) (4)
- How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa (2019) (3)
- Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa.Curr Opin Oncol. 2006 Sep;18(5):479-86. Review.PMID: 16894296 [PubMed - indexed for MEDLINE] (2006) (3)
- Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country (2021) (3)
- Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. (2021) (3)
- Clinical characterization, cardiovascular risk factor profile and cardiac strain analysis in a Uganda cancer population: The SATRACD study (2021) (3)
- ER, PR, and HER2 expression in Ugandan breast cancer patients: An evaluation of in-country RT-PCR compared to IHC. (2020) (3)
- United against cancer: prevention to end-of-life care—highlights from the Uganda Cancer Institute–Palliative Care Association of Uganda Joint International Conference on Cancer and Palliative Care and the 7th Palliative Care Conference, 24–25 August 2017, Kampala, Uganda (2017) (3)
- Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting (2020) (3)
- Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute (2018) (3)
- Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute (2021) (3)
- Anatomical site predilections of non-Hodgkin's lymphoma in human immunodeficiency virus infection: a report on 54 cases. (2004) (2)
- Turnaround time and barriers to treatment of newly diagnosed cancer in Uganda: a mixed-methods longitudinal study (2022) (2)
- Increased oral Epstein-Barr virus shedding with HIV-1 co-infection is due to a combination of B cell activation and impaired cellular immune control (2019) (2)
- Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants. (2020) (2)
- Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care. (2021) (2)
- Dose-modified oral chemotherapy for AIDS-related non-Hodgkin's lymphoma (AR-NHL) in East Africa. (2006) (2)
- “We Shall Tell them with Love, Inform them what we have Learnt and then Allow them to go” - Men’s Perspectives of Self-Collected Cervical Cancer Screening in Rural Uganda: A Qualitative Inquiry (2022) (2)
- Psychometric properties of the EORTC QLQ-C30 in Uganda (2021) (2)
- EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report. (2015) (2)
- The social and economic impacts of cervical cancer on women and children in low‐ and middle‐income countries: A systematic review (2022) (2)
- Clinical profile and initial treatment of non-small cell lung cancer: a retrospective cohort study at the Uganda Cancer Institute (2021) (2)
- IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute (2021) (2)
- 169. Multidrug-Resistant Bacteria Are Common Cause of Neutropenic Fever and Increase Mortality Among Patients with Hematologic Malignancies in Uganda (2019) (2)
- TRANSLATION AND DETERMINATION OF THE COMPREHENSIBILITY OF A LUGANDA VERSION OF ORAL MUCOSITIS DAILY QUESTIONNAIRE. (2021) (2)
- Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop (2022) (2)
- AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy (2009) (2)
- Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey (2013) (2)
- A health care professionals training needs assessment for oncology in Uganda (2020) (1)
- Using a Novel Peer Mentoring Program to Foster Conversion from Mentee to Mentor Among Clinician/Researchers-in-Training in Uganda (2016) (1)
- Impact of a Quality Improvement Project on Pediatric Endemic Burkitt Lymphoma Outcomes in Uganda (2016) (1)
- Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis (2022) (1)
- High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma. (2017) (1)
- HIV related malignancies in Kenya (2003) (1)
- Oesophageal cancer management guidelines for Uganda (2008) (1)
- The Role of South-to-South Partnerships in Developing Cancer Services in Africa (2018) (1)
- Identifying predictors of increased quantities of human Herpesvirus 8 DNA detection at oropharyngeal and plasma sites among Ugandan adults with and without HIV and Kaposi Sarcoma (2012) (1)
- Identifying predictors of increased quantities of human Herpesvirus 8 DNA detection at oropharyngeal and plasma sites among Ugandan adults with and without HIV and Kaposi Sarcoma (2012) (1)
- Breast Cancer Clinical Trials: The Landscape at the Uganda Cancer Institute and Lessons Learned (2021) (1)
- Analyses of Prognostic Factors for Survival in East African Patients with AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) Treated with Dose Modified Oral Chemotherapy. (2006) (1)
- A novel peer mentoring consultant program for career development of clinician-scientists in Uganda (2015) (1)
- The profile and causes of death among medical doctors and dental surgeons in Uganda: 1986 to 2016 (2022) (1)
- Cancer and palliative care in COVID-19 and other challenging situations—highlights from the Uganda Cancer Institute—Palliative Care Association of Uganda 3rd Uganda Conference on Cancer and Palliative Care, 23–24 September 2021, held in Kampala, Uganda and virtually (2021) (1)
- Interrogation of HHV-8 transcriptome in KS tumors and association with KS presentation and outcomes in Uganda (2015) (1)
- Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis (2013) (1)
- Building Modern Cancer Care Services in Sub-Saharan Africa Based on a Clinical-Research Care Model. (2022) (1)
- Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men (2021) (1)
- Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study (2021) (1)
- Community-Integrated Self-Collection HPV-Based Cervix Screening Programs to Increase Screening and Treatment Coverage: Results from a Pragmatic, Cluster-Randomized Trial (2022) (1)
- Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma (2017) (1)
- Dose-Modified Oral Chemotherapy for AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) in East Africa. (2006) (1)
- Tele-Oncology: A Joint Web-Based Clinical Conference Between the Uganda Cancer Institute and the Fred Hutch Cancer Research Center (2016) (1)
- Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction (2016) (1)
- KEY GENETIC AND MOLECULAR ABERRATIONS IDENTIFIED IN BOTH ADULT AND EBV‐POSITIVE BURKITT LYMPHOMA PATIENTS (2021) (1)
- Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting (2012) (1)
- Access to cancer chemotherapy and predictors of early mortality for childhood cancers in Uganda. (2013) (1)
- Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute (2020) (1)
- Experiences with thermal ablation for cervical precancer treatment after self‐collection HPV‐based screening in the ASPIRE Mayuge randomized trial (2022) (1)
- Treatment Recommendations for Patients with NHL at the Uganda Cancer Institute (2013) (1)
- Prostate Cancer Burden at the Uganda (2016) (0)
- Abstract B93: Clinical characteristics, treatment, and outcome of childhood Burkitt's lymphoma in the Uganda Cancer Institute (2011) (0)
- Original article Survival by AIDS defining condition in rural (2000) (0)
- Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy (2022) (0)
- Survival of patients with cancer associated thrombosis at the Uganda Cancer Institute (2021) (0)
- Detecting subclinical anthracycline therapy-related cardiac dysfunction in patients attending Uganda Cancer Institute. (2022) (0)
- Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children (2017) (0)
- Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda (2022) (0)
- Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality (2018) (0)
- Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing (2015) (0)
- Achieving the cancer moonshot in Africa (2022) (0)
- Prognosis and delay of diagnosis among Kaposi’s sarcoma patients in Uganda: a cross-sectional study (2014) (0)
- HIV Associated Non-Hodgkin's Lymphomas Primary Anatomical Sites Predilections (2012) (0)
- Burkitt lymphoma. (2019) (0)
- Capacity building for cancer prevention and early detection in the Ugandan primary healthcare facilities: Working toward reducing the unmet needs of cancer control services (2020) (0)
- HIV and Malignancy in Children (2014) (0)
- Outcomes of endemic Burkitt lymphoma patients treated using a patient-oriented approach (2016) (0)
- COPY NUMBER VARIATION ANALYSIS IDENTIFIES DISTINCT GENOMIC FEATURES IN ADULT BURKITT LYMPHOMA (2021) (0)
- Multiple High Risk and Non-Vaccine HPV Types in Ugandan Women Living with HIV on Long-Term Antiretroviral Therapy (2021) (0)
- Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma (2014) (0)
- Participation in HIV Care Is Associated with Decreased Time to Cancer Treatment in those with HIV-associated Malignancy in Uganda (2016) (0)
- Evaluation of a predictive staging model for Kaposi sarcoma in Uganda. (2015) (0)
- A prospective study of HIV-associated and hiv-negative kaposi sarcoma in Uganda: identifying factors associated with poor outcomes. (2022) (0)
- Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma (2021) (0)
- 226. Multidrug Resistant Polymicrobial Gram-negative Bacteremia in Hematologic Cancer Patients with Febrile Neutropenia at the Uganda Cancer Institute (2021) (0)
- Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute (2020) (0)
- Challenges of Building and Sustaining Radiation Therapy Capacity in Low-Resource Settings: A Case of the Breakdown of Cobalt 60 Teletherapy in Uganda and Lessons Learned (2018) (0)
- Little Hands Beating Cancer: Building Resource Capacity for Cancer Control in Sub-Saharan Africa (2018) (0)
- The prevalence and distribution of non-communicable diseases and their risk factors in Kasese district, Uganda : research article (2016) (0)
- HIV and predictors of advanced cancer at presentation: Uganda. (2014) (0)
- Psychometric Properties of the EORTC QLQ-C30 in a Ugandan Context (2020) (0)
- Integrative proteomics and genomics supports a role for interferon gamma in the pathogenesis of Kaposi sarcoma and finds multiple candidate diagnostic proteins for early detection or prevention (2010) (0)
- Infection-related cancers in Africa : a new paradigm for prevention and control efforts (2012) (0)
- A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda (2022) (0)
- Whole Exome Analysis Reveals Key Genomic Differences between Sporadic and Endemic Pediatric Burkitt Lymphoma (2018) (0)
- Documentation of HIV Testing and Treatment Status Among Patients Presenting for Cancer Care in Uganda (2016) (0)
- Burkitt lymphoma. (2022) (0)
- HPV genotype and EGFR activation in conjunctival carcinoma among HIV patients in East Africa (2010) (0)
- Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting (2020) (0)
- Patient-reported oral mucositis in solid tumour patients undergoing chemotherapy: a Ugandan experience (2023) (0)
- Comparison Of Treatment Outcomes Between Epoch And Chop Regimens In Patients With Hiv Associated Nhl In A Low Resource Setting (2020) (0)
- Etiological risk factors and clinical characteristics of childhood non-Hodgkin lymphoma in Uganda (2014) (0)
- Virus associated Non-Hodgkin’s Lymphoma show anatomical sites predilections (2005) (0)
- Dose-modified Oral Chemotherapy for AIDS-related non-Hodgkin’s Lymphoma in E.A (2012) (0)
- Prognosis, diagnostic delay, and patient characteristics associated with diagnostic delay among Kaposi sarcoma (KS) patients in Uganda. (2013) (0)
- Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa. (2023) (0)
- IMPROVING TREATMENT OUTCOMES FOR CHILDREN WITH ENDEMIC BURKITT LYMPHOMA (eBL) IN SUB-SAHARAN AFRICA (SSA) (2022) (0)
- Pathology and Cancer Research (2015) (0)
- Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute (2022) (0)
- DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features (2022) (0)
- Prostate cancer burden at the Uganda Cancer Institute (UCI). (2015) (0)
- 241 Care for cervical cancer patients in uganda is scarce; evaluation of clinical presentation and management in kampala (2019) (0)
- Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting (2012) (0)
- Community-integrated self-collected HPV-based cervix screening in a low-resource rural setting: a pragmatic, cluster-randomized trial (2023) (0)
This paper list is powered by the following services:
Other Resources About Jackson Orem
What Schools Are Affiliated With Jackson Orem?
Jackson Orem is affiliated with the following schools:
